It has initially been shown that overexpression of apoC-III in mice results in hypertriglyceridemia [49] whereas depletion of apoC-III decreases plasma TG levels and protects from postprandial hypertriglyceridemia [50]. This evidence concerns the gene APOC3 and hypertriglyceridemia.